Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	345.79

NSE Code	DRREDDY
Dividend Yield %	0.64
Market Cap	1044935.71

P/E	19.53
EPS	64.10
Face Value	1


	BSE		NSE

04-Jun-2025

Last Price	1252.15
Net Change	3.55
% Change	0.28%
Prev.Close	1248.60
Open	1251.95
High	1266.00
Low	1246.65
Volume	45082

Last Price	1251.90
Net Change	3.6
% Change	0.29%
Prev.Close	1248.30
Open	1248.30
High	1266.00
Low	1246.30
Volume	1387633

Value	56641413
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1266.00
52-Week High	1420.20
52-Week Low	1025.90

Value	1741113658.8
Best Buy	0.00
Best Sell	1251.90
Best Quantity	0
Sell Quantity	39
Today's Range	1266.00
52-Week High	1421.49
52-Week Low	1020.00

Open Price	1252.60
High Price	1265.00
Low Price	1250.80
Last Price	1255.30
Prev Close	1249.10
Change	6.20
% Change	0.50 %

Average Price	1256.31
Underlying Value	1251.90
Number of contracts traded	2238
Turnover in Rs. Lakhs	17573
Open Interest	10356880.00
Change in O I	-65620.00
% Change in O I	-0.63 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	39
Price	1251.90

Best Bid

Best Offer

Quantity	1250
Price	1255.4

Quantity	625
Price	1256.2

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

17-Jul-24

Company News

26-05-2025

USFDA completes GMP inspe...

17-05-2025

USFDA completes GMP inspe...

17-05-2025

Dr Reddys Laboratories in...

10-05-2025

Dr. Reddy’s Laboratories ...

10-05-2025

Dr Reddys Laboratories in...

10-05-2025

Dr. Reddy's Laboratories ...

09-05-2025

Dr Reddys Laboratories in...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.